Critical limb ischemia (CLI) patients have poor long-term prognosis. We showed that iloprost improves outcomes (major amputation and survival) up a 5-year follow-up, but it is not known if in this length of time the survival curves, of clinical responders and non-responders, differ.
Long-term survival of patients with critical limb ischemia treated with iloprost: response rate and predictive criteria. A retrospective analysis of 102 patients
BERCHIOLLI, RAFFAELLA NICE
Co-primo
;
2016-01-01
Abstract
Critical limb ischemia (CLI) patients have poor long-term prognosis. We showed that iloprost improves outcomes (major amputation and survival) up a 5-year follow-up, but it is not known if in this length of time the survival curves, of clinical responders and non-responders, differ.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Long term survival of patients with critical limb ischemia treated with iloprost response rate and predictive criteria. A retrospective analysis of 102 patients.pdf
accesso aperto
Tipologia:
Versione finale editoriale
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
388.89 kB
Formato
Adobe PDF
|
388.89 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
